Conservative Management of Left Ventricular Assist Device Candidates

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

Left ventricular assist device (LVAD) candidates will be comprehensively evaluated at our center, including clinical evaluation, echocardiography, right heart catheterization, cardiopulmonary exercise test and laboratory exams. following this evaluation, patients will be treated with inotropes, diuretics, uptitrated neurohormonal therapy. vitamin and iron deficiencies will be corrected and the patients will be referred for coronary interventions and cardiac resynchronization therapy appropriately. The need for LVAD implantation will be reevaluated according to the patient's clinical condition, echocardiography and laboratory findings.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 80
View:

• \- left ventricular ejection fraction \<35%. New York Heart Association Class III or IV. Brain natriuretic peptide levels \> 450pg/ml. Heart failure hospitalization in the past 6 months. Maximal oxygen consumption \< 12 ml/kg/min. Intolerant to conventional heart failure therapy.

Locations
Other Locations
Israel
Tel Aviv Sourasky Medical Center
RECRUITING
Tel Aviv
Contact Information
Primary
Ofer Havakuk, MD
oferh@tlvmc.gov.il
+97236974250
Time Frame
Start Date: 2018-01-01
Estimated Completion Date: 2028-01
Participants
Target number of participants: 100
Related Therapeutic Areas
Sponsors
Leads: Tel-Aviv Sourasky Medical Center

This content was sourced from clinicaltrials.gov